EMA

Xpansiv Acquires APX to Scale Environmental Commodity Market Infrastructure

By NewsOnFloor 15 Apr 2023

Advertisment

CSL Vifor and Travere Therapeutics announce EMA has accepted for review the Conditional Marketing Authorization application for sparsentan for the treatment of IgA Nephropathy

A review decision by the European Medicines Agency (EMA) is expected in the second half of 2023 If approved, sparsentan will be a first-in-class treatment to address the significant unmet medical nee

By NewsOnFloor 11 Apr 2023

Share LinkedIn

Business

Xpansiv to Acquire Evolution Markets Expanding the World is Leading Environmental Market Infrastructure

Xpansiv, the premier market-infrastructure platform for environmental commodities, today announced an agreement to acquire Evolution Markets, a leading brokerage firm in global carbon, renewable, and

By NewsOnFloor 08 Apr 2023

Share LinkedIn

Business

Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases

− Company to Feature 15 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology − Oral Presentations Include Updated Results from Phase 3 OPTIC Trial of ICLUSIG® (ponatinib) and

By NewsOnFloor 04 Apr 2023

Share LinkedIn

Web Stories